XERS
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. (XERS) has 14 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 7, 2026.
The most active filer is See Remarks Hecht Beth with 4 filings. Insiders have net sold $2.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:John Shannon
- Employees:394
- HQ:Chicago, IL, US
- IPO:2018-06-21
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Pieper StevenFirst filing | See Remarks | Sale | 17,400 | $148K | Jul 7 | SEC ↗ |
Pieper StevenFirst filing | See Remarks | Sale | 27,600 | $235K | Jul 7 | SEC ↗ |
McCulloch KevinFirst filing | See Remarks | Sale | 90,000 | $723K | Jul 2 | SEC ↗ |
| See Remarks | Sale | 16,666 | $134K | Jul 2 | SEC ↗ | |
PERSKY MARLAFirst filing | Director | Sale | 15,500 | $91K | Jun 5 | SEC ↗ |
HALKUFF DAWNFirst filing | Director | Sale | 20,000 | $122K | Jun 5 | SEC ↗ |
| Director | Sale | 15,000 | $91K | Jun 5 | SEC ↗ | |
BORMANN-KENNEDY BARBARA-JEAN ANNEFirst filing | Director | Sale | 16,000 | $98K | Jun 5 | SEC ↗ |
| See Remarks | Sale | 16,667 | $101K | Jun 2 | SEC ↗ | |
| See Remarks | Sale | 16,667 | $104K | May 1 | SEC ↗ | |
Hecht BethFirst filing | See Remarks | Sale | 16,667 | $100K | Apr 3 | SEC ↗ |
Brady James AloysiusFirst filing | Director | Sale | 10,834 | $60K | Apr 1 | SEC ↗ |
Related companies
Xeris Biopharma Holdings, Inc. is in the Healthcare sector.